Advertisement
Canada markets open in 8 hours 10 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7305
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    82.94
    +0.13 (+0.16%)
     
  • Bitcoin CAD

    87,846.11
    -3,733.53 (-4.08%)
     
  • CMC Crypto 200

    1,389.51
    -34.59 (-2.43%)
     
  • GOLD FUTURES

    2,328.60
    -9.80 (-0.42%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,442.50
    -222.00 (-1.26%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,689.51
    -770.57 (-2.00%)
     
  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Stocks - Tilray, Newell Brands Jump in Premarket; Walgreen’s, Pier 1, ConAgra Fall

Investing.com - Stocks in focus in premarket trade Thursday:

• Walgreens Boots Alliance (NASDAQ:WBA) fell 1.8% at 8:30 AM ET (13:30 GMT) after it reported quarterly sales that were a tad lower than expectations. The drugstore chain owner did reaffirm full-year profit guidance.

• Tilray (NASDAQ:TLRY) soared 12% on news the cannabis company is teaming up with Anheuser Busch Inbev (NYSE:BUD) to research cannabis-infused non-alcoholic beverages.

• ConAgra Foods (NYSE:CAG) slipped 5% after it issued full-year profit guidance that was lower than consensus estimates, despite handily beating on the bottom line in its most recent quarter.

ADVERTISEMENT

• Pier 1 Imports (NYSE:PIR) plunged 10% after reporting a quarterly loss that was much wider than expected and also missed on sales. The retailer also appointed an interim CEO.

• Newell Brands (NASDAQ:NWL) stock gained 5% after activist investor Carl Icahn revealed in a regulatory filing that he now owns 9.89% of the company, up from 8.1%.

• Rite Aid (NYSE:RAD) shares jumped 13% after the company reported earnings and sales in line with expectations and announced a 10-year pharmaceutical distribution deal with McKesson (NYSE:MCK).

Related Articles

Apple faces iPhone ban in Germany

BGC Partners sees paying Q4 dividend of about 14 cents per share

Dreams of Higher Treasury Yields Fade as Fed Fuels Flatter Curve